CDLX.NASDAQCardlytics, INC

8-K: Cardlytics Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Focus on Growth and Positive Adjusted EBITDA in 2025

Sentiment:

Earnings Release


Cardlytics announces its Q4 and full year 2024 financial results, highlighting a challenging year but expressing confidence in a return to growth and positive Adjusted EBITDA in 2025.

Worse than expectedThe company's revenue and Adjusted EBITDA decreased for both the fourth quarter and full year 2024, indicating a decline in financial performance.The company anticipates a negative Adjusted EBITDA for Q1 2025, suggesting continued challenges in the near term.Cardlytics ARPU decreased for both Q4 and the full year 2024.Cardlytics MAUs in the quarter decreased by 0.4% compared to the fourth quarter of 2023.

Summary

  • Cardlytics reported a decrease in total revenue for both the fourth quarter and full year 2024.
  • Total revenue for Q4 2024 was $74.0 million, a 17.0% decrease compared to $89.2 million in Q4 2023.
  • Total revenue for the full year 2024 was $278.3 million, a 10.0% decrease compared to $309.2 million in 2023.
  • The company's Net Loss decreased significantly in Q4 2024 to $(15.6) million from $(100.8) million in Q4 2023.
  • However, the Net Loss for the full year 2024 was $(189.3) million, compared to $(134.7) million in 2023.
  • Adjusted EBITDA decreased to $6.4 million in Q4 2024 from $10.0 million in Q4 2023.
  • Adjusted EBITDA for the full year 2024 was $2.5 million, compared to $3.8 million in 2023.
  • Cardlytics anticipates Q1 2025 billings to be between $91.5 million and $94.5 million, revenue between $57.0 million and $60.0 million, and a negative Adjusted EBITDA between $(7.5) million and $(4.0) million.
  • The company is focused on strengthening its competitive position through platform modernization, product enhancement, and network expansion.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company acknowledges a challenging year and declining revenue, it expresses confidence in future growth and positive Adjusted EBITDA. The improved net loss in Q4 is a positive sign, but the overall financial performance is still weak.

Positives

  • Net loss significantly decreased in Q4 2024 compared to Q4 2023, indicating improved cost management.
  • The company is focused on platform modernization and product enhancement, which could lead to future growth.
  • Management expresses confidence in achieving positive Adjusted EBITDA in 2025.
  • Cardlytics MAUs for the full year 2024 increased by 3.0% compared to 2023.

Negatives

  • Total revenue decreased for both Q4 and the full year 2024, indicating a decline in business activity.
  • Adjusted EBITDA decreased for both Q4 and the full year 2024.
  • The company anticipates a negative Adjusted EBITDA for Q1 2025.
  • Cardlytics ARPU decreased for both Q4 and the full year 2024.
  • Cardlytics MAUs in the quarter decreased by 0.4% compared to the fourth quarter of 2023.

Risks

  • Unfavorable conditions in the global economy could impact the company's performance.
  • The company is substantially dependent on a limited number of financial institution partners.
  • The amount and timing of budgets by marketers can affect the company's revenue.
  • The company's ability to adapt to changing market conditions is crucial for its success.
  • The company's quarterly operating results have fluctuated and may continue to vary from period to period.

Future Outlook

Cardlytics anticipates sequential improvements and positive Adjusted EBITDA in 2025, with Q1 2025 guidance provided for Billings, Revenue, Adjusted Contribution, and Adjusted EBITDA.

Management Comments

  • Amit Gupta, CEO, stated that 2024 was a challenging year but the company has refocused its efforts to get back on track for growth in 2025.
  • Amit Gupta, CEO, emphasized the company's focus on strengthening its competitive moat through platform modernization, product enhancement, and network expansion.
  • Alexis DeSieno, CFO, stated that the company is focused on delivering sequential improvements and positive Adjusted EBITDA in 2025.
  • Alexis DeSieno, CFO, expressed confidence in the company's ability to invest in its business while satisfying all financial obligations.

Industry Context

Cardlytics operates in the digital advertising space, competing with other platforms that connect marketers with consumers through various channels. The company's focus on financial institution partnerships and transaction data provides a unique value proposition, but it also faces challenges related to data privacy and regulatory compliance.

Comparison to Industry Standards

  • It's difficult to directly compare Cardlytics' results to industry standards without knowing the specific performance of its direct competitors in the card-linked marketing space.
  • Companies like Rakuten Advertising and Quotient Technology also operate in the digital advertising and rewards space, but their business models and target markets may differ.
  • Cardlytics' reliance on financial institution partnerships distinguishes it from broader digital advertising platforms like Google and Facebook.
  • A key benchmark would be the growth rate of digital advertising spend in general, and the performance of other companies leveraging transaction data for marketing purposes.

Stakeholder Impact

  • Shareholders may be concerned about the declining revenue and Adjusted EBITDA, but encouraged by the improved net loss in Q4 and management's confidence in future growth.
  • Employees may face uncertainty due to the company's restructuring and focus on efficiency.
  • Financial institution partners may be impacted by changes in the company's strategy and performance.
  • Marketers may see opportunities to leverage the company's platform for targeted advertising, but also face risks related to data privacy and regulatory compliance.

Next Steps

  • Cardlytics will hold a teleconference on March 12, 2025, to discuss the financial results.
  • The company will focus on platform modernization, product enhancement, and network expansion to drive future growth.
  • Cardlytics will aim to deliver sequential improvements and positive Adjusted EBITDA in 2025.

Key Dates

DateDescription
March 12, 2025Date of press release and earnings teleconference.
December 31, 2024End of the fourth quarter and full year 2024.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.